Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 16/20 | 0.57 |
| ▸ | ITGA4 | P13612 | 16/20 | 0.57 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | WNT3A | P56704 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7388623 | 0.92 | ITGB1 (0.51) | ITGB1ITGA4ITGB7POLBSMN1; SMN2 | |
| SCHEMBL7535873 | 0.91 | ITGA4 (0.55) | ITGB1ITGA4ITGB7WNT3A | |
| SCHEMBL7385307 | 0.90 | ITGB1 (0.57) | ITGB1ITGA4ITGB7 | |
| SCHEMBL7587137 | 0.89 | ITGB1 (0.61) | ITGB1ITGA4ITGB7 | |
| SCHEMBL7647698 | 0.89 | ITGB1 (0.61) | ITGB1ITGA4ITGB7 | |
| SCHEMBL7587157 | 0.89 | ITGB1 (0.61) | ITGB1ITGA4ITGB7 | |
| SCHEMBL7419462 | 0.89 | ITGA4 (0.61) | ITGB1ITGA4ITGB7POLB | |
| SCHEMBL5700868 | 0.89 | ITGB1 (0.70) | ITGB1ITGA4ITGB7 | |
| SCHEMBL5700863 | 0.89 | ITGB1 (0.70) | ITGB1ITGA4ITGB7 | |
| SCHEMBL7561313 | 0.89 | ITGB1 (0.63) | ITGB1ITGA4ITGB7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| EP-1027328-A1 | SUBSTITUTED ANILIDES | Aventis Pharma Limited (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999023063-A1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LIMITED (GB) | 1999-05-14 | — | — | WO | disclosed |